Latest Breaking News On - Celularity inc - Page 29 : comparemela.com

Short Interest in Celularity Inc (NASDAQ:CELU) Expands By 8 8%

Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, a growth of 8.8% from the March 15th total of 4,750,000 shares. Approximately 7.4% of the company’s shares are short sold. Based on […]

Hb wealth managementAllspring global investments holdingsMorgan stanleyCelularity incRenaissance technologiesCelularity company profileGet ratingGlobal investments holdingsStreet groupCell therapyDegenerative diseaseCelularity dailyNasdaq celu

CELULARITY INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)

Item 1.01 Entry into a Material Definitive Agreement. Registered Direct Offering On April 4, 2023, Celularity Inc, or Celularity, entered into a securities purchase agreement with an institutional. | April 7, 2023

Goodwin procterYa ii pn ltdAlliance global partnersPlacement agency agreementExchange commissionCelularity incMaterial definitivePurchase agreementGlobal partnersCurrent reportCommon stock purchaseAgency agreementPage interactive data fileEdgar onlineCelularity inc stock exchangePress release

Celularity (CELU) Announces $6 Million Registered Direct Offering

Celularity (CELU) Announces $6 Million Registered Direct Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesExchange commissionA gp alliance global partnersCelularity incAlliance global partners

Celularity Receives U S Food And Drug Administration (FDA) Preliminary Assessment For Celularity s Investigational Fuse Bone Void Filler To Be Regulated As A Device By FDA s Center For Devices And Radiological Health

Celularity’s Pre-Request for Designation is based on data demonstrating 100 percent biochemical characterization of the product Celularity intends to submit 510 pre-market notification to the. | April 3, 2023

United statesUnited arab emiratesRobertj haririAbu dhabiAd ports groupRadiologic healthDrug administrationSecurities exchangeCelularity incGlobenewswire incCh trading groupRadiological healthMarket researchExchange commissionOffice of combination productsGrowing middle east distribution agreements

Short Interest in Celularity Inc (NASDAQ:CELU) Grows By 38 1%

Celularity Inc. (NASDAQ:CELU – Get Rating) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 4,750,000 shares, a growth of 38.1% from the February 28th total of 3,440,000 shares. Currently, 9.2% of the company’s shares are sold short. Based on […]

York mellon corpBlackrock incB riley financial incCelularity incMorgan stanleyVanguard group incGet ratingStreet corpRiley financialNew york mellon corpCell therapyDegenerative diseaseCelularity dailyNasdaq celu